Sabby Management’s Mirati Therapeutics, Inc. Common Stock MRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | – | Hold |
0
| – | – | – | 133 |
|
|
2021
Q4 | – | Sell |
-5,000
| Closed | -$885K | – | 145 |
|
|
2021
Q3 | $885K | Sell |
5,000
-1,000
| -17% | -$177K | 0.12% | 49 |
|
|
2021
Q2 | $969K | Sell |
6,000
-2,500
| -29% | -$404K | 0.14% | 44 |
|
|
2021
Q1 | $1.46M | Buy |
8,500
+5,500
| +183% | +$942K | 0.28% | 32 |
|
|
2020
Q4 | $659K | Buy |
+3,000
| New | +$659K | 0.13% | 25 |
|
|
2017
Q3 | – | Sell |
-255,100
| Closed | -$921K | – | 147 |
|
|
2017
Q2 | $921K | Buy |
255,100
+5,365
| +2% | +$19.4K | 0.06% | 41 |
|
|
2017
Q1 | $1.3M | Buy |
249,735
+150,000
| +150% | +$780K | 0.07% | 33 |
|
|
2016
Q4 | $474K | Hold |
99,735
| – | – | 0.03% | 90 |
|
|
2016
Q3 | $659K | Sell |
99,735
-7,500
| -7% | -$49.6K | 0.02% | 89 |
|
|
2016
Q2 | $586K | Buy |
107,235
+50,835
| +90% | +$278K | 0.03% | 107 |
|
|
2016
Q1 | $1.21M | Buy |
56,400
+30,373
| +117% | +$650K | 0.06% | 76 |
|
|
2015
Q4 | $822K | Sell |
26,027
-33,973
| -57% | -$1.07M | 0.05% | 92 |
|
|
2015
Q3 | $2.07M | Buy |
+60,000
| New | +$2.07M | 0.09% | 60 |
|
|
2014
Q1 | – | Sell |
-12,213
| Closed | -$203K | – | 138 |
|
|
2013
Q4 | $203K | Buy |
+12,213
| New | +$203K | 0.01% | 66 |
|